These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2449616)

  • 41. Beneficial effects of buprenorphine (a partial opiate agonist) in porcine Escherichia coli septicaemia: a comparison with naloxone.
    Donaldson MD; Vesey CJ; Wilks M; Hinds CJ
    Circ Shock; 1988 Jul; 25(3):209-21. PubMed ID: 3048768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Administration and dosage of flunitrazepam in combination with analgesics].
    Milewski P; Dick W
    Klin Anasthesiol Intensivther; 1978; (17):148-62. PubMed ID: 28436
    [No Abstract]   [Full Text] [Related]  

  • 43. Naloxone reversal of ketobemidone induced respiratory, circulatory and narcotic effects in dogs.
    Aasen AO; Holst-Larsen H; Ormstad K; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():118-28. PubMed ID: 19923
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effects of naloxone (Narcan) on circulation and respiration after neurolept anaesthesia for neurosurgical operations (author's transl)].
    Huse K; Hartung E; Nadjmabadi MH
    Anaesthesist; 1974 Nov; 23(11):493-9. PubMed ID: 4458474
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute opioid physical dependence in humans: naloxone dose response effects.
    Heishman S; Stitzer M
    NIDA Res Monogr; 1988; 81():195-201. PubMed ID: 3136361
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
    Carroll CP; Walsh SL; Bigelow GE; Strain EC; Preston KL
    Exp Clin Psychopharmacol; 2006 May; 14(2):109-20. PubMed ID: 16756415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antinociceptive efficacy of buprenorphine and hydromorphone in red-eared slider turtles (Trachemys scripta elegans).
    Mans C; Lahner LL; Baker BB; Johnson SM; Sladky KK
    J Zoo Wildl Med; 2012 Sep; 43(3):662-5. PubMed ID: 23082538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of buprenorphin on circulation, respiration and the electroencephalogram (a postoperative study of 12 neurosurgical cases) (author's transl)].
    Huse K; Stahl HJ; Krämer M
    Prakt Anaesth; 1978 Dec; 13(6):489-94. PubMed ID: 740629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological adjuncts in the treatment of opiate dependence.
    Resnick RB
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs.
    Pypendop B; Serteyn D; Verstegen J
    Am J Vet Res; 1996 May; 57(5):724-30. PubMed ID: 8723890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Morphine and beta-endorphin in the S-region of the ventral surface of the medulla oblongata: respiratory and cardiovascular effects].
    Flórez J; Mediavilla A; Hurlé M
    Arch Farmacol Toxicol; 1981 Apr; 7(1):45-8. PubMed ID: 6275803
    [No Abstract]   [Full Text] [Related]  

  • 53. Buprenorphine in combination with naloxone at a ratio of 15:1 does not enhance antinociception from buprenorphine in healthy cats.
    Slingsby LS; Murrell JC; Taylor PM
    Vet J; 2012 Jun; 192(3):523-4. PubMed ID: 22030474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nature and incidence of conditioned responses in a methadone population: a comparison of laboratory, clinic, and naturalistic settings.
    Childress AR; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1986; 67():366-72. PubMed ID: 3092092
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts.
    Campbell H; Cline W; Evans M; Lloyd J; Peck AW
    Eur J Clin Pharmacol; 1973 Oct; 6(3):170-6. PubMed ID: 4586849
    [No Abstract]   [Full Text] [Related]  

  • 57. Study of naloxone in normal awake man: effects on heart rate and respiration.
    Willer JC; Boureau F; Dauthier C; Bonora M
    Neuropharmacology; 1979 May; 18(5):469-72. PubMed ID: 460543
    [No Abstract]   [Full Text] [Related]  

  • 58. Updating our language around substance use disorders.
    Xie E; Green S; Puri N; Sheikh H
    CMAJ; 2017 Dec; 189(50):E1566. PubMed ID: 29255103
    [No Abstract]   [Full Text] [Related]  

  • 59. New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.
    Soyka M
    Subst Abuse Rehabil; 2015; 6():1-14. PubMed ID: 25610012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependence.
    Mauger S; Fraser R; Gill K
    Neuropsychiatr Dis Treat; 2014; 10():587-98. PubMed ID: 24741316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.